| pubmed-article:3977885 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:3977885 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:3977885 | lifeskim:mentions | umls-concept:C0027950 | lld:lifeskim |
| pubmed-article:3977885 | lifeskim:mentions | umls-concept:C0009498 | lld:lifeskim |
| pubmed-article:3977885 | lifeskim:mentions | umls-concept:C0000275 | lld:lifeskim |
| pubmed-article:3977885 | lifeskim:mentions | umls-concept:C0030054 | lld:lifeskim |
| pubmed-article:3977885 | lifeskim:mentions | umls-concept:C2004454 | lld:lifeskim |
| pubmed-article:3977885 | lifeskim:mentions | umls-concept:C1304680 | lld:lifeskim |
| pubmed-article:3977885 | lifeskim:mentions | umls-concept:C0205332 | lld:lifeskim |
| pubmed-article:3977885 | lifeskim:mentions | umls-concept:C0870883 | lld:lifeskim |
| pubmed-article:3977885 | lifeskim:mentions | umls-concept:C0033268 | lld:lifeskim |
| pubmed-article:3977885 | lifeskim:mentions | umls-concept:C1261512 | lld:lifeskim |
| pubmed-article:3977885 | lifeskim:mentions | umls-concept:C0699795 | lld:lifeskim |
| pubmed-article:3977885 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:3977885 | pubmed:dateCreated | 1985-4-4 | lld:pubmed |
| pubmed-article:3977885 | pubmed:abstractText | Luminol-enhanced chemiluminescence demonstrated that 2-chloroadenosine inhibited complement-induced reactive oxygen metabolite production in human polymorphonuclear leucocytes. This inhibition was reversed by 8-phenyltheophylline. Binding of a [125I]-labelled monoclonal antibody against C9 to human PMN demonstrated removal of membrane attack complexes from the cell membranes, and in addition indicated inhibition of this process by 2-chloroadenosine. This compound also increased the percentage of complement-induced cell lysis of polymorphonuclear leucocytes. | lld:pubmed |
| pubmed-article:3977885 | pubmed:language | eng | lld:pubmed |
| pubmed-article:3977885 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3977885 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:3977885 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3977885 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3977885 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3977885 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3977885 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3977885 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3977885 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:3977885 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:3977885 | pubmed:issn | 0006-291X | lld:pubmed |
| pubmed-article:3977885 | pubmed:author | pubmed-author:CampbellA KAK | lld:pubmed |
| pubmed-article:3977885 | pubmed:author | pubmed-author:RobertsP APA | lld:pubmed |
| pubmed-article:3977885 | pubmed:author | pubmed-author:MorganB PBP | lld:pubmed |
| pubmed-article:3977885 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:3977885 | pubmed:day | 31 | lld:pubmed |
| pubmed-article:3977885 | pubmed:volume | 126 | lld:pubmed |
| pubmed-article:3977885 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:3977885 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:3977885 | pubmed:pagination | 692-7 | lld:pubmed |
| pubmed-article:3977885 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:3977885 | pubmed:meshHeading | pubmed-meshheading:3977885-... | lld:pubmed |
| pubmed-article:3977885 | pubmed:meshHeading | pubmed-meshheading:3977885-... | lld:pubmed |
| pubmed-article:3977885 | pubmed:meshHeading | pubmed-meshheading:3977885-... | lld:pubmed |
| pubmed-article:3977885 | pubmed:meshHeading | pubmed-meshheading:3977885-... | lld:pubmed |
| pubmed-article:3977885 | pubmed:meshHeading | pubmed-meshheading:3977885-... | lld:pubmed |
| pubmed-article:3977885 | pubmed:meshHeading | pubmed-meshheading:3977885-... | lld:pubmed |
| pubmed-article:3977885 | pubmed:meshHeading | pubmed-meshheading:3977885-... | lld:pubmed |
| pubmed-article:3977885 | pubmed:meshHeading | pubmed-meshheading:3977885-... | lld:pubmed |
| pubmed-article:3977885 | pubmed:meshHeading | pubmed-meshheading:3977885-... | lld:pubmed |
| pubmed-article:3977885 | pubmed:meshHeading | pubmed-meshheading:3977885-... | lld:pubmed |
| pubmed-article:3977885 | pubmed:meshHeading | pubmed-meshheading:3977885-... | lld:pubmed |
| pubmed-article:3977885 | pubmed:year | 1985 | lld:pubmed |
| pubmed-article:3977885 | pubmed:articleTitle | 2-Chloroadenosine inhibits complement-induced reactive oxygen metabolite production and recovery of human polymorphonuclear leucocytes attacked by complement. | lld:pubmed |
| pubmed-article:3977885 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:3977885 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3977885 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3977885 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3977885 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3977885 | lld:pubmed |
